4 results
The objective of this study is to obtain clinical performance (outcomes) data andsurvivorship for commercially available Zimmer Persona knee implants implanted inprimary total knee arthroplasty.
Primary objective:To demonstrate the efficacy of Rifaximin -EIR 400 mg Tablet (800mg /BID, total daily dose 1600 mg) versus placebo in the prevention of endoscopic Crohn*s disease recurrence following ileocolonic resection
To determine the test-retest variability of Compass perimetry at the edges of glaucomatous scotomas and compare it with the Humphrey Field Analyzer.
The objective of this study is to obtain clinical performance (outcomes) data and survivorship for commercially available Zimmer Persona knee implants implanted in primary total knee arthroplasty.